glp-1 drug made by eli lilly FDA approves new weight-loss pill, Foundayo GLP-1 weight loss could soon

Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials

But they also directly impact liver health

Seven of these trials are expected to report results in 2026

PMID: 16529340 DOI: 10.1331/154434506775268698 Tushuizen ME et al (2006): Incretin mimetics as a novel therapeutic option for hepatic steatosis

Discontinuing treatment can result in weight regain, so a comprehensive, long-term approach is crucial

Research suggests that coffee may help increase GLP-1 release, thanks to polyphenols rather than caffeine itself